Please read these important legal notices and disclosures
None of the information displayed on or downloadable from https://www.precize.in represents an offer to buy or sell or a solicitation of an offer to buy or sell any security, nor does it constitute an offer to provide investment advice or service. Registered representatives of precize do not (1) Advise any member on the merits or advisability of a particular investment or transaction, or (2) Assist in the determination of fair value of any security or investment, or (3) Provide legal, tax, or transactional advisory services.
API Holdings (Pharmeasy) Unlisted Share Price Today
52-week range ₹6 to ₹8.
ISIN INE0DJ201029.
API Holdings (Pharmeasy) has developed a healthcare delivery platform to simplify and modernize the healthcare setup in India. Data and technology are the driving factors behind a robust health and well-being ecosystem today, and API Holdings (Pharmeasy) is leveraging both to strengthen healthcare in India. Industry Analysis The Indian healthcare market, valued at US$ 110 billion in 2016, is projected to reach US$ 638 billion by 2025. As of 2024, the sector employs 7.5 million individuals, po…
API Holdings (Pharmeasy)

The Indian healthcare market, valued at US$ 110 billion in 2016, is projected to reach US$ 638 billion by 2025. As of 2024, the sector employs 7.5 million individuals, positioning it as one of the largest employment sectors in the country. However, the industry faces a critical shortage of healthcare professionals, with only 1.7 nurses per 1,000 people and a doctor-patient ratio of 1:1,500. As a result, the demand for healthcare professionals in India is expected to double by 2030. In response to these challenges, the 2024-25 Union Budget has allocated Rs. 89,287 crores (US$ 10.7 billion), which includes Rs. 50,000 crores (US$ 6.8 billion) for a dedicated credit program aimed at enhancing healthcare infrastructure and expanding digital services.
(Source: Industry Research Report and Annual Report)
Founded in 2012, API Holdings has established itself as a leader in India's digital healthcare sector. Operating under the brand name PharmEasy, it has grown to become the country’s largest digital healthcare platform, as measured by the GMV of products and services sold as of March 31, 2021. Headquartered in Ghatkopar West, Mumbai, the company offers an integrated, end-to-end solution designed to meet the healthcare needs of a wide range of consumers. API Holdings provides services to diverse stakeholders, including consumers, pharmaceutical companies, wholesalers, pharmacies, hospitals, doctors, clinics, and diagnostic labs, creating a seamless and connected healthcare ecosystem throughout India.